Velvio GmbH

Business Strategies

Velvio develops new compounds to restore organ repair functions as treatment for Orphan Diseases in Neurodegeneration (like Amyotrophic Lateral Sclerosis -  ALS) and Idiopathic Pulmonary Fibrosis (IPF and preterm infants` Broncho Pulmonary Dysplasia - BPD). Further Velvio offers new opportunities in Immune-Oncology enhancing response of solid tumors to treatment concepts in Liver and in Brain Tumors.

Core Technologies and Services

Drug development